Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 420

1.

Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.

Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL.

J Pathol. 2006 Jul;209(3):307-16.

PMID:
16604511
2.

Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.

Ellsworth RE, Ellsworth DL, Weyandt JD, Fantacone-Campbell JL, Deyarmin B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2010 Jun;17(6):1688-94. doi: 10.1245/s10434-010-0910-x. Epub 2010 Jan 27.

PMID:
20107913
4.

Timing of critical genetic changes in human breast disease.

Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2005 Dec;12(12):1054-60. Epub 2005 Oct 10.

PMID:
16228814
5.
6.

[Early loss of heterozygosity on chromosome arm 16q in flat epithelial atypia of the breast. Detection by microsatellite analyses].

Schmidt H, Dahrenmöller C, Agelepoulos K, Hungermann D, Böcker W.

Pathologe. 2008 Nov;29 Suppl 2:328-32. doi: 10.1007/s00292-008-1042-y. German.

PMID:
18807038
7.

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC.

J Natl Cancer Inst. 1998 May 6;90(9):697-703.

PMID:
9586667
8.

Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.

Xu S, Wei B, Zhang H, Qing M, Bu H.

Oncol Rep. 2008 Jun;19(6):1469-75.

PMID:
18497952
9.

Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.

Gao Y, Niu Y, Wang X, Wei L, Lu S.

J Mol Med (Berl). 2009 Feb;87(2):145-52. doi: 10.1007/s00109-008-0408-1. Epub 2008 Oct 21.

PMID:
18936904
10.

Molecular alterations in columnar cell lesions of the breast.

Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S.

Mod Pathol. 2006 Mar;19(3):344-9.

11.

Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E.

Cancer Res. 1996 Nov 15;56(22):5260-5.

13.
14.

Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast.

Amari M, Moriya T, Ishida T, Harada Y, Ohnuki K, Takeda M, Sasano H, Horii A, Ohuchi N.

Jpn J Clin Oncol. 2003 Nov;33(11):556-62.

PMID:
14711979
15.

LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia.

Amari M, Suzuki A, Moriya T, Yoshinaga K, Amano G, Sasano H, Ohuchi N, Satomi S, Horii A.

Oncol Rep. 1999 Nov-Dec;6(6):1277-80.

PMID:
10523696
16.
17.

Loss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast.

Kaneko M, Arihiro K, Takeshima Y, Fujii S, Inai K.

J Exp Ther Oncol. 2002 Jan-Feb;2(1):9-18.

PMID:
12415615
18.
19.

Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ.

Am J Pathol. 1997 Jan;150(1):297-303.

20.

Correlation of levels and patterns of genomic instability with histological grading of DCIS.

Ellsworth RE, Ellsworth DL, Love B, Patney HL, Hoffman LR, Kane J, Hooke JA, Shriver CD.

Ann Surg Oncol. 2007 Nov;14(11):3070-7. Epub 2007 Jun 5.

PMID:
17549568

Supplemental Content

Support Center